Medpace Holdings, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Medpace Holdings, Inc. (MEDP) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $577.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-07-23
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $577.00K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $577.00K.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $620.00K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $620.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $577.00K 10-Q · filed 2026-07-23 |
| 2026-03-31 | $577.00K 10-Q · filed 2026-04-23 |
| 2025-12-31 | $620.00K 10-K · filed 2026-02-10 |
| 2025-09-30 | $620.00K 10-Q · filed 2025-10-23 |
| 2025-06-30 | $620.00K 10-Q · filed 2025-07-22 |
| 2025-03-31 | $620.00K 10-Q · filed 2025-04-22 |
| 2024-12-31 | $946.00K 10-K · filed 2025-02-11 |
| 2024-09-30 | $946.00K 10-Q · filed 2024-10-22 |
| 2024-06-30 | $946.00K 10-Q · filed 2024-07-23 |
| 2024-03-31 | $946.00K 10-Q · filed 2024-04-23 |
| 2023-12-31 | $1.44M 10-K · filed 2024-02-13 |
| 2023-09-30 | $1.44M 10-Q · filed 2023-10-24 |
| 2023-06-30 | $1.44M 10-Q · filed 2023-07-25 |
| 2023-03-31 | $1.44M 10-Q · filed 2023-04-25 |
| 2022-12-31 | $2.20M 10-K · filed 2023-02-14 |
| 2022-09-30 | $2.20M 10-Q · filed 2022-10-25 |
| 2022-06-30 | $2.20M 10-Q · filed 2022-07-26 |
| 2022-03-31 | $2.20M 10-Q · filed 2022-04-26 |
| 2021-12-31 | $3.35M 10-K · filed 2022-02-15 |
| 2021-09-30 | $3.35M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $3.35M 10-Q · filed 2021-07-27 |
| 2021-03-31 | $3.35M 10-Q · filed 2021-04-27 |
| 2020-12-31 | $5.11M 10-K · filed 2021-02-16 |
| 2020-09-30 | $5.11M 10-Q · filed 2020-10-27 |
| 2019-12-31 | $7.88M 10-K · filed 2020-02-25 |
| 2018-12-31 | $14.83M 10-K · filed 2019-02-26 |
| 2017-12-31 | $29.56M 10-K · filed 2018-02-27 |
| 2016-12-31 | $37.79M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |